Smitha S Krishnamurthi

6PUBLICATIONS
42CO-AUTHORS
Technology, crime and surveillanceMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 06, 2024
Expert Commentary on ctDNA Testing for Minimal Residual Disease Assessment and Surveillance.

Smitha S Krishnamurthi

|Jun 18, 2024
Improved Survival With Adjuvant Cyclooxygenase 2 Inhibition in PIK3CA-Activated Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance).

Jonathan A Nowak, Tyler Twombly, Chao Ma

|Oct 11, 2023
Circulating Tumor DNA in Colorectal Cancer Liver Metastasis: Analysis of Patients Receiving Liver Resection and Transplant.

Chase J Wehrle, Roma Raj, Nihal Aykun

|Jun 08, 2023
Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance).

Qiao-Li Wang, Chao Ma, Chen Yuan

|Nov 11, 2022
Potential Mediators of Oxaliplatin-Induced Peripheral Neuropathy From Adjuvant Therapy in Stage III Colon Cancer: Findings From CALGB (Alliance)/SWOG 80702.

Seohyuk Lee, Chao Ma, Qian Shi

|Aug 09, 2022
Physical Activity in Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance).

Justin C Brown, Chao Ma, Qian Shi

Pageof 1